<DOC>
	<DOCNO>NCT01375478</DOCNO>
	<brief_summary>This open-label , retrospective , observational study evaluate compliance RoActemra/Actemra ( tocilizumab ) therapy patient moderate severe rheumatoid arthritis . Six month data collect patient record .</brief_summary>
	<brief_title>An Observational Study RoActemra/Actemra Patients With Moderate Severe Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , 18 year age Moderate severe rheumatoid arthritis RoActemra/Actemra treatment must initiate 6 month prior sign inform consent form Patients rheumatic autoimmune disease rheumatoid arthritis Patients willing sign inform consent form Patients participate interventional trial period observational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>